美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

BridgeBio Oncology Therapeutics, Inc

7.81

-0.4200-5.10%

盘后：7.960.1500+1.92%19:32 EDT

成交量：30.56万

成交额：237.03万

市值：6.25亿

市盈率：-2.59

高：8.26

开：8.26

低：7.63

收：8.23

52周最高：14.87

52周最低：7.60

股本：7,998.87万

流通股本：4,460.40万

量比：1.83

换手率：0.69%

股息：- -

股息率：- -

每股收益(TTM):-3.0184

每股收益(LYR):-4.3039

净资产收益率：-62.21%

总资产收益率：-37.20%

市净率：1.68

市盈率(LYR):-1.81

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

BridgeBio Oncology Therapeutics公布2026年第一季度财报及公司进展

BridgeBio子公司Bbot获美国FDA快速通道资格 Bbo-11818用于治疗晚期KRAS突变胰腺导管腺癌成人患者

BridgeBio Oncology Therapeutics, Inc：更新版一期临床数据预计将于2026年下半年公布

Bridgebio Oncology Therapeutics, Inc.盘中异动下午盘股价大涨5.11%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BBOT"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBOT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBOT\",,,,,undefined,":{"symbol":"BBOT","market":"US","secType":"STK","nameCN":"BridgeBio Oncology Therapeutics, Inc","latestPrice":7.81,"timestamp":1780689600000,"preClose":8.23,"halted":0,"volume":305636,"hourTrading":{"tag":"盘后","latestPrice":7.96,"preClose":7.81,"latestTime":"19:32 EDT","volume":3537,"amount":27775.17,"timestamp":1780702363454,"change":0.15,"changeRate":0.019206,"amplitude":0.019206},"delay":0,"changeRate":-0.05103280680437434,"floatShares":44603977,"shares":79988687,"eps":-3.018446,"marketStatus":"休市中","change":-0.42,"latestTime":"06-05 16:00:00 EDT","open":8.26,"high":8.26,"low":7.63,"amount":2370315.0695080003,"amplitude":0.076549,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.018446,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1780905600000},"marketStatusCode":7,"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":8.23,"postHourTrading":{"tag":"盘后","latestPrice":7.96,"preClose":7.81,"latestTime":"19:32 EDT","volume":3537,"amount":27775.17,"timestamp":1780702363454,"change":0.15,"changeRate":0.019206,"amplitude":0.019206},"volumeRatio":1.828937478560686},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBOT\",,,,,undefined,":{"symbol":"BBOT","floatShares":44603977,"roa":"-37.20%","roe":"-62.21%","lyrEps":-4.3039,"volumeRatio":1.828937478560686,"shares":79988687,"dividePrice":0,"high":8.26,"amplitude":0.076549,"preClose":8.23,"low":7.63,"week52Low":7.6,"pbRate":"1.68","week52High":14.87,"institutionHeld":0,"latestPrice":7.81,"eps":-3.018446,"divideRate":0,"volume":305636,"delay":0,"ttmEps":-3.018446,"open":8.26,"prevYearClose":12.52,"prevWeekClose":8.97,"prevMonthClose":8.97,"prevQuarterClose":8.95,"fiveDayClose":8.97,"twentyDayClose":7.86,"sixtyDayClose":9.99},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBOT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-12","symbol":"BBOT","fiscalQuarterEnding":"2026/03","expectedEps":-0.51,"name":null,"time":"盘后","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.53},{"market":"US","date":"2026-03-05","symbol":"BBOT","fiscalQuarterEnding":"2025/12","expectedEps":-0.67,"name":null,"time":"盘后","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-11-12","symbol":"BBOT","fiscalQuarterEnding":"2025/09","expectedEps":-0.41,"name":null,"time":"盘后","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-1.03},{"market":"US","date":"2025-08-01","symbol":"BBOT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1754020800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-05-15","symbol":"BBOT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBOT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBOT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1778558400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBOT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBOT","date":"2026-06-05","current":-2.587424,"percent":0.99,"low":-11.944957,"twenty":-10.091924,"median":-8.379277,"eighty":-5.319839,"high":-4.174438,"avg":-7.942963,"sd":2.241279,"marketCap":659281465},"quantilePoints":[{"date":"2025-08-22","current":-9.544109,"twenty":-10.820609,"median":-9.81087,"eighty":-9.532253,"marketCap":835109579},{"date":"2025-08-29","current":-9.336629,"twenty":-9.787158,"median":-9.514469,"eighty":-9.277349,"marketCap":816955023},{"date":"2025-09-05","current":-9.959071,"twenty":-9.864223,"median":-9.514469,"eighty":-9.247708,"marketCap":871418691},{"date":"2025-09-12","current":-10.047991,"twenty":-10.065775,"median":-9.65773,"eighty":-9.388005,"marketCap":879199215},{"date":"2025-09-19","current":-10.690193,"twenty":-10.20212,"median":-9.78123,"eighty":-9.467045,"marketCap":935391888},{"date":"2025-09-26","current":-11.678196,"twenty":-11.017222,"median":-9.944251,"eighty":-9.487793,"marketCap":1021842155},{"date":"2025-10-03","current":-11.259509,"twenty":-11.190123,"median":-10.077631,"eighty":-9.526325,"marketCap":985207072},{"date":"2025-10-10","current":-11.196152,"twenty":-11.224546,"median":-10.323455,"eighty":-9.563869,"marketCap":979663302},{"date":"2025-10-17","current":-10.3182,"twenty":-11.192532,"median":-10.372506,"eighty":-9.601414,"marketCap":902842494},{"date":"2025-10-24","current":-9.838494,"twenty":-11.156298,"median":-10.223893,"eighty":-9.601414,"marketCap":860868237},{"date":"2025-10-31","current":-10.861263,"twenty":-11.08659,"median":-10.23674,"eighty":-9.656742,"marketCap":950360520},{"date":"2025-11-07","current":-11.087539,"twenty":-11.118284,"median":-10.345353,"eighty":-9.745662,"marketCap":970159697},{"date":"2025-11-14","current":-11.205203,"twenty":-11.201583,"median":-10.472068,"eighty":-9.804136,"marketCap":980455269},{"date":"2025-11-21","current":-8.47671,"twenty":-11.192532,"median":-10.345353,"eighty":-9.572151,"marketCap":974262207},{"date":"2025-11-28","current":-8.567184,"twenty":-11.17443,"median":-10.251046,"eighty":-9.478901,"marketCap":984660736},{"date":"2025-12-05","current":-8.0313,"twenty":-11.121014,"median":-10.182434,"eighty":-9.298176,"marketCap":923069447},{"date":"2025-12-12","current":-8.936039,"twenty":-11.105583,"median":-10.084778,"eighty":-9.061365,"marketCap":1027054741},{"date":"2025-12-19","current":-8.389716,"twenty":-11.080298,"median":-9.97426,"eighty":-8.826299,"marketCap":964263621},{"date":"2025-12-26","current":-8.490629,"twenty":-11.051335,"median":-9.938056,"eighty":-8.720294,"marketCap":975861981},{"date":"2026-01-02","current":-8.713334,"twenty":-11.00789,"median":-9.919954,"eighty":-8.650698,"marketCap":1001458361},{"date":"2026-01-09","current":-9.256178,"twenty":-10.960825,"median":-9.809862,"eighty":-8.597806,"marketCap":1063849537},{"date":"2026-01-16","current":-8.003462,"twenty":-10.901088,"median":-9.61327,"eighty":-8.567184,"marketCap":919869900},{"date":"2026-01-23","current":-7.829474,"twenty":-10.885701,"median":-9.557912,"eighty":-8.530995,"marketCap":899872728},{"date":"2026-01-30","current":-8.699415,"twenty":-10.880305,"median":-9.521034,"eighty":-8.553265,"marketCap":999858587},{"date":"2026-02-06","current":-7.063925,"twenty":-10.867923,"median":-9.470009,"eighty":-8.485061,"marketCap":811885173},{"date":"2026-02-13","current":-7.947786,"twenty":-10.83411,"median":-9.398729,"eighty":-8.38554,"marketCap":913470805},{"date":"2026-02-20","current":-7.043047,"twenty":-10.812388,"median":-9.272371,"eighty":-8.35979,"marketCap":809485512},{"date":"2026-02-27","current":-7.13352,"twenty":-10.763512,"median":-9.179623,"eighty":-8.144045,"marketCap":819884041},{"date":"2026-03-06","current":-6.882977,"twenty":-10.695084,"median":-9.036987,"eighty":-8.006246,"marketCap":791088114},{"date":"2026-03-13","current":-5.451193,"twenty":-10.678337,"median":-8.936039,"eighty":-7.945698,"marketCap":730699673},{"date":"2026-03-20","current":-5.403428,"twenty":-10.588779,"median":-8.821207,"eighty":-7.854528,"marketCap":724297048},{"date":"2026-03-27","current":-5.510899,"twenty":-10.477499,"median":-8.762051,"eighty":-7.489849,"marketCap":738702956},{"date":"2026-04-02","current":-5.391486,"twenty":-10.453966,"median":-8.733947,"eighty":-7.421645,"marketCap":722696391},{"date":"2026-04-10","current":-5.287,"twenty":-10.379747,"median":-8.713334,"eighty":-7.088979,"marketCap":708690647},{"date":"2026-04-17","current":-5.504928,"twenty":-10.361645,"median":-8.657658,"eighty":-7.020776,"marketCap":737902628},{"date":"2026-04-24","current":-5.355662,"twenty":-10.30763,"median":-8.605462,"eighty":-6.799463,"marketCap":717894422},{"date":"2026-05-01","current":-5.021307,"twenty":-10.25963,"median":-8.567184,"eighty":-5.98855,"marketCap":673076041},{"date":"2026-05-08","current":-4.692922,"twenty":-10.225879,"median":-8.553265,"eighty":-5.587323,"marketCap":629057988},{"date":"2026-05-15","current":-4.419866,"twenty":-10.182434,"median":-8.490629,"eighty":-5.506122,"marketCap":681079323},{"date":"2026-05-22","current":-4.73149,"twenty":-10.167401,"median":-8.47671,"eighty":-5.429101,"marketCap":729099017},{"date":"2026-05-29","current":-4.595521,"twenty":-10.107271,"median":-8.403635,"eighty":-5.355662,"marketCap":708146799},{"date":"2026-06-05","current":-4.278409,"twenty":-10.091924,"median":-8.379277,"eighty":-5.319839,"marketCap":659281465}],"updateTime":1780858333472},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBOT\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1197660362","title":"BridgeBio Oncology Therapeutics公布2026年第一季度财报及公司进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1197660362","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197660362?lang=zh_cn&edition=fundamental","pubTime":"2026-05-13 06:09","pubTimestamp":1778623778,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology Therapeutics, Inc. 发布了其2026年第一季度的财务业绩，并同步更新了公司运营的最新进展。根据报告，公司目前的现金储备预计足以支持其运营持续至2028年。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194150244","title":"BridgeBio子公司Bbot获美国FDA快速通道资格 Bbo-11818用于治疗晚期KRAS突变胰腺导管腺癌成人患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1194150244","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194150244?lang=zh_cn&edition=fundamental","pubTime":"2026-04-21 04:08","pubTimestamp":1776715708,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology Therapeutics, Inc（简称Bbot）宣布，其针对晚期KRAS突变胰腺导管腺癌成人患者的创新疗法Bbo-11818，已获得美国食品药品监督管理局（FDA）授予的快速通道资格。这一认定将加速该候选药物的研发和审评进程，为存在迫切未满足医疗需求的患者群体带来新的治疗希望。\n胰腺导管腺癌作为最常见的胰腺癌类型，其KRAS突变亚型长期以来缺乏有效靶向治疗方案。快速通道资格的获得，不仅体现了Bbo-11818在早期研究中展现出的治疗潜力，也意味着该药物在后续临床试验中可获得与FDA更频繁的沟通交流机会，有望更快推进至上市申请阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181220084","title":"BridgeBio Oncology Therapeutics, Inc：更新版一期临床数据预计将于2026年下半年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1181220084","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181220084?lang=zh_cn&edition=fundamental","pubTime":"2026-04-21 04:08","pubTimestamp":1776715701,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology Therapeutics, Inc 近日透露，其备受关注的一期临床试验更新数据预计在2026年下半年揭晓。这一时间表的公布，为关注该公司研发进展的投资者与行业观察者提供了明确预期。\n此次数据更新对于评估相关候选药物的安全性与初步疗效具有关键意义。公司研发管线的最新动态，或将影响其未来的临床开发策略与市场定位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612424818","title":"Bridgebio Oncology Therapeutics, Inc.盘中异动 下午盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612424818","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612424818?lang=zh_cn&edition=fundamental","pubTime":"2026-02-19 03:45","pubTimestamp":1771443943,"startTime":"0","endTime":"0","summary":"北京时间2026年02月19日03时45分，Bridgebio Oncology Therapeutics, Inc.股票出现异动，股价大幅拉升5.11%。Bridgebio Oncology Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Bridgebio Oncology Therapeutics, Inc.公司简介：BridgeBio Oncology Therapeutics Inc，前身为BridgeBio Oncology Therapeutics，是一家临床阶段生物技术公司，旨在改变由两种经常发生突变的致癌基因RAS和PI3Ka驱动的癌症的患者生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219034544a7080f77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219034544a7080f77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBOT","LENZ","BK4139","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BBOT\",params:#limit:6,delay:false,,,undefined,":[]}}